ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $208,000 | -1.4% | 8,085 | 0.0% | 0.00% | – |
Q2 2021 | $211,000 | -63.2% | 8,085 | -50.2% | 0.00% | -100.0% |
Q1 2021 | $574,000 | +33.2% | 16,246 | -3.3% | 0.00% | – |
Q4 2020 | $431,000 | -29.7% | 16,801 | +5.6% | 0.00% | -100.0% |
Q3 2020 | $613,000 | +0.5% | 15,910 | +11.6% | 0.00% | 0.0% |
Q2 2020 | $610,000 | +130.2% | 14,260 | +4.9% | 0.00% | – |
Q1 2020 | $265,000 | – | 13,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
Navalign, LLC | 74,271 | $623,000 | 0.26% |
PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |